
|Articles|February 24, 2020
Raremark Partners With TriNetX
Advertisement
TriNetX has announced that Raremark has partnered with their network to bring more clinical trials to its community. Raremark builds communities of people affected by a rare condition, sharing knowledge, and collecting real-world experience.
For more information on this partnership, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg
2
FDA Approves Caplyta as Adjunctive Therapy for Major Depressive Disorder Based on Positive Phase III Results
3
Using AI and Tokenized Data to Match Patients to Protocols
4






.png)



.png)



.png)
.png)
